Teva Sued Over HIV Medicine Patent
August 9, 2011
According to Bloomberg, Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, was sued by a joint venture of GlaxoSmithKline Plc and Pfizer Inc. for infringing a U.S. patent for the HIV drug Epzicom. Teva has applied to the U.S. Food and Drug Administration for permission to sell generic Epzicom tablets in violation of a 2002 patent, lawyers for ViiV Healthcare said in an Aug. 5 complaint filed in federal court in Wilmington, Del. Teva’s FDA submission “constitutes infringement” and “ViiV will be irreparably harmed” by the low-cost version of Epzicom if it’s sold before the patent expires in 2016, according to court papers.